Wedbush Starts Medifast (MED) at Outperform; Rise In Overweight Individuals Is Not Limited To The U.S.
Tweet Send to a Friend
Wedbush initiates coverage on Medifast (NYSE: MED) with a Outperform. PT $32.
Wedbush analyst says, "Our top pick is Medifast ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Our top pick is Medifast ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
